Relapsed or Refractory Large B-cell Lymphoma

Explore clinical trials studying Relapsed or Refractory Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Relapsed or Refractory Large B-cell Lymphoma trial results

Recruiting

NCT07479797

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States

Stanford University Stanford, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta Newnan, Georgia, United States

Recruiting

NCT06788964

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

Not Yet Recruiting

NCT07670260

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

Completed

NCT05459571

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States

UCLA Los Angeles, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States

View all 16 locations